These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35692159)

  • 1. Design, Synthesis, Anti-microbial and Molecular Docking Studies of Novel 5-Pyrazyl-2-Sulfanyl-1, 3, 4-Oxadiazole Derivatives.
    Das R; Mehta DK; Gupta S; Dhanawat M
    Recent Adv Antiinfect Drug Discov; 2022; 17(2):118-130. PubMed ID: 35692159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents.
    Desai NC; Somani H; Trivedi A; Bhatt K; Nawale L; Khedkar VM; Jha PC; Sarkar D
    Bioorg Med Chem Lett; 2016 Apr; 26(7):1776-83. PubMed ID: 26920799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation and Docking Study of Pyrazine Containing 1, 3, 4-Oxadiazoles Clubbed with Substituted Azetidin-2-one: A New Class of Potential Antimicrobial and Antitubercular.
    Das R; Mehta DK
    Drug Res (Stuttg); 2021 Jan; 71(1):26-35. PubMed ID: 33027823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, computational molecular docking studies of novel heterocyclics bearing 1,2,4-triazole, 1,3,4-oxadiazole conjugates as potent antibacterial and antitubercular agents.
    Sravanthi B; Himavathi G; Robert AR; Karunakar P; Kiran KS; Maddila S
    J Biomol Struct Dyn; 2024 Jul; 42(10):5376-5389. PubMed ID: 37340639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel antituberculosis agents among 3-phenyl-5-(1-phenyl-1H-[1,2,3]triazol-4-yl)-[1,2,4]oxadiazole derivatives targeting aminoacyl-tRNA synthetases.
    Rybak MY; Balanda AO; Yatsyshyna AP; Kotey IM; Starosyla SA; Bdzhola VG; Lukash LL; Yarmoluk SM; Tukalo MA; Volynets GP
    Sci Rep; 2021 Mar; 11(1):7162. PubMed ID: 33785838
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Deb PK; Al-Shar'i NA; Venugopala KN; Pillay M; Borah P
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):869-884. PubMed ID: 34060396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and in vitro antituberculosis activity of benzo[6,7]cyclohepta[1,2-b]pyridine-1,3,4-oxadiazole derivatives.
    Sajja Y; Vanguru S; Vulupala HR; Nagarapu L; Perumal Y; Sriram D; Nanubolu JB
    Chem Biol Drug Des; 2017 Oct; 90(4):496-500. PubMed ID: 28267891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of alkynylated 1,2,4-oxadiazole/1,2,3-1H-triazole glycoconjugates: Discovering new compounds for use in chemotherapy against lung carcinoma and Mycobacterium tuberculosis.
    Melo de Oliveira VN; Flávia do Amaral Moura C; Peixoto ADS; Gonçalves Ferreira VP; Araújo HM; Lapa Montenegro Pimentel LM; Pessoa CDÓ; Nicolete R; Versiani Dos Anjos J; Sharma PP; Rathi B; Pena LJ; Rollin P; Tatibouët A; Nascimento de Oliveira R
    Eur J Med Chem; 2021 Aug; 220():113472. PubMed ID: 33940463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological evaluation of (E)-5-styryl-1,2,4-oxadiazoles as anti-tubercular agents.
    Atmaram Upare A; Gadekar PK; Sivaramakrishnan H; Naik N; Khedkar VM; Sarkar D; Choudhari A; Mohana Roopan S
    Bioorg Chem; 2019 May; 86():507-512. PubMed ID: 30776681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, antituberculosis studies and biological evaluation of new quinoline derivatives carrying 1,2,4-oxadiazole moiety.
    Shruthi TG; Eswaran S; Shivarudraiah P; Narayanan S; Subramanian S
    Bioorg Med Chem Lett; 2019 Jan; 29(1):97-102. PubMed ID: 30448235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of nitrofuran-1,3,4-oxadiazole hybrids as new antitubercular agents.
    Wang A; Xu S; Chai Y; Xia G; Wang B; Lv K; Wang D; Qin X; Jiang B; Wu W; Liu M; Lu Y
    Bioorg Med Chem; 2022 Jan; 53():116529. PubMed ID: 34861474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and in silico study of pyridine based 1,3,4-oxadiazole embedded hydrazinecarbothioamide derivatives as potent anti-tubercular agent.
    Ambhore AN; Kamble SS; Kadam SN; Kamble RD; Hebade MJ; Hese SV; Gaikwad MV; Meshram RJ; Gacche RN; Dawane BS
    Comput Biol Chem; 2019 Jun; 80():54-65. PubMed ID: 30901601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, Biological Evaluation and Computational Studies of New Hydrazide Derivatives Containing 1,3,4-Oxadiazole as Antitubercular Agents.
    Zampieri D; Fortuna S; Romano M; De Logu A; Cabiddu G; Sanna A; Mamolo MG
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
    Lokesh BVS; Prasad YR; Shaik AB
    Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antitubercular activity of new 1,3,4-oxadiazoles bearing pyridyl and thiazolyl scaffolds.
    Dhumal ST; Deshmukh AR; Bhosle MR; Khedkar VM; Nawale LU; Sarkar D; Mane RA
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3646-51. PubMed ID: 27301367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of new 4-pyrrol-1-yl benzoic acid hydrazide analogs and some derived oxadiazole, triazole and pyrrole ring systems: a novel class of potential antibacterial and antitubercular agents.
    Joshi SD; Vagdevi HM; Vaidya VP; Gadaginamath GS
    Eur J Med Chem; 2008 Sep; 43(9):1989-96. PubMed ID: 18207286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, Molecular Docking, and Biological Evaluation of Some Novel 2- (5-Substituted 1,3,4-oxadiazole-2-yl)-1,3-benzothiazole Derivatives as Anticonvulsant Agents.
    Khokra SL; Kaur S; Banwala S; Wadhwa K; Husain A
    Cent Nerv Syst Agents Med Chem; 2021; 21(2):130-141. PubMed ID: 34109917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of new indanol-1,2,3-triazole derivatives as potent antitubercular and antimicrobial agents.
    Phatak PS; Bakale RD; Kulkarni RS; Dhumal ST; Dixit PP; Krishna VS; Sriram D; Khedkar VM; Haval KP
    Bioorg Med Chem Lett; 2020 Nov; 30(22):127579. PubMed ID: 32987135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of some novel 2-substituted-5-[isopropylthiazole] clubbed 1,2,4-triazole and 1,3,4-oxadiazoles as potential antimicrobial and antitubercular agents.
    Suresh Kumar GV; Rajendraprasad Y; Mallikarjuna BP; Chandrashekar SM; Kistayya C
    Eur J Med Chem; 2010 May; 45(5):2063-74. PubMed ID: 20149496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of water-soluble 3,5-dinitrophenyl tetrazole and oxadiazole antitubercular agents.
    Roh J; Karabanovich G; Vlčková H; Carazo A; Němeček J; Sychra P; Valášková L; Pavliš O; Stolaříková J; Klimešová V; Vávrová K; Pávek P; Hrabálek A
    Bioorg Med Chem; 2017 Oct; 25(20):5468-5476. PubMed ID: 28835350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.